Redistribution of cytochrome c and AIF has been reported to be an early event of the apoptotic process.[46–48] To evaluate the enhancement of glioma cell cytotoxicity by the combination of dasatinib and JSI-124, we examined the involvement of cytochrome c and AIF by immunofluorescence microscopy. The gene discussed is CYCS; the disease is glioma.